This paper describes the preparation and potential use of zinc phosphate nanoparticles with bound TNF-alpha analogues. TNF-alpha bound in such nanoparticles has reduced biological activity, but conserved epitopes, so such particles would be useful for active immunotherapy in chronic inflammatory diseases where TNF-alpha levels are significantly increased.
COBISS.SI-ID: 4607770
The chapter in the international publication describes the use of zinc phosphate in different biomedical applications, especially as implants and bone replacement materials, nucleic acid delivery, vaccine adjuvant and as a delivery system for different drugs.
COBISS.SI-ID: 512245816
A process for isolation of biologically active G-CSF is disclosed, enabling the separation of correctly folded biologically active monomeric G-CSF from the incorrectly folded, biologically inactive monomeric, oligo- or polymeric and also from aggregated molecules of G-CSF using affinity chromatography IMAC. The process can be advantageously performed under native conditions. Only 2 additional chromatographic steps, CEX and SEC, are needed for polishing. The process results in the high-yield of G-CSF with a purity of greater than 99% and is particularly suitable for industrial production.
COBISS.SI-ID: 4156698
Pegylation is an efficient methodology for half-life extension of proteins. Most of the positive pharmacological effects are usually ascribed to increased molecular size. To explore the impact of PEG on in vitro potency, a series of well-defined conjugates of IFN were prepared with PEGs of different lengths and shapes attached to the N-terminus of the protein. Beside of the expected impact of increased molecular size, the studies revealed high correlation between in vitro potency and chromatographic behavior on CEC, both methods reflecting the protein masking effect by the attached PEG moiety.
COBISS.SI-ID: 4143898
This paper describes an alternative approach to develop new forms of therapeutic molecules based on protein dimerization. Such a principle was used to prepare different G-CSF dimers and their pegylated conjugates with the aim to obtain a dimer with enhanced therapeutic properties. Similar principles could be used also to prepare different TNF-based particles.
COBISS.SI-ID: 1452892